OCS compared with EVMN: revenue, margins and what each company keeps, and the suppliers and customers both name

OCSOculis Holding AG

Mkt capRevenueRevenue

EVMNEvommune, Inc.

Mkt capRevenueRevenue

Compare

OCSOculis Holding AG

EVMNEvommune, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

OCS

No earnings history for OCS.

EVMN

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▲+5.23%—

May 8 '26±38.2%▲+1.87%×0.05

Q1 FY26—▲+5.62%—

Q3 FY25—▼−8.53%—

= impliedOCS realized, solidEVMN realized, hatchedOne scale, both sides: full bar = 39%× = |realized| ÷ impliedSource: market data

OCSOculis Holding AG

7.73· pre 7.73· delayed

Mkt cap$463.3MRevenue—

EVMNEvommune, Inc.

6.72· pre 5.98· delayed

Pre-marketNov 3 '26delayed

Mkt cap$217.2MRevenue$10MQ3 FY25

Compare

Pre-marketNov 3 '26delayed

OCSOculis Holding AG

EVMNEvommune, Inc.

7.73pre 7.73delayed

Price

6.72pre 5.98delayed

$463.3M

Mkt cap

$217.2M

—

Revenue

$10MQ3 FY25

OCS7.73vsEVMN6.72Pre-marketNov 3 '26delayed